This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2010 Mar;11(3):277-81.

doi: 10.2217/pgs.10.38.

HLA: a pharmacogenomics success story

Laurent Becquemont

PMID: 20235781
DOI: 10.2217/pgs.10.38

Review

HLA: a pharmacogenomics success story

Laurent Becquemont. Pharmacogenomics. 2010 Mar.

. 2010 Mar;11(3):277-81.

doi: 10.2217/pgs.10.38.

Author

Laurent Becquemont

PMID: 20235781
DOI: 10.2217/pgs.10.38

No abstract available

PubMed Disclaimer

Similar articles

[The associations between idiosyncratic adverse drug reactions and HLA alleles and their underlying mechanism].
Wang Q, Mei H, Zhang YL, Pan XC, Tan W, Chao L. Wang Q, et al. Yao Xue Xue Bao. 2013 Jun;48(6):799-808. Yao Xue Xue Bao. 2013. PMID: 23984511 Review. Chinese.
Pharmacogenetics of allopurinol--making an old drug safer.
Lam MP, Yeung CK, Cheung BM. Lam MP, et al. J Clin Pharmacol. 2013 Jul;53(7):675-9. doi: 10.1002/jcph.67. Epub 2013 Feb 4. J Clin Pharmacol. 2013. PMID: 23381951 Review.
HLA-associated drug hypersensitivity and the prediction of adverse drug reactions.
Negrini S, Becquemont L. Negrini S, et al. Pharmacogenomics. 2017 Oct;18(15):1441-1457. doi: 10.2217/pgs-2017-0090. Epub 2017 Oct 11. Pharmacogenomics. 2017. PMID: 29017379 Review.
The role of HLA genes in pharmacogenomics: unravelling HLA associated adverse drug reactions.
Illing PT, Purcell AW, McCluskey J. Illing PT, et al. Immunogenetics. 2017 Aug;69(8-9):617-630. doi: 10.1007/s00251-017-1007-5. Epub 2017 Jul 10. Immunogenetics. 2017. PMID: 28695285 Review.
Pharmacogenomics of adverse drug reactions: practical applications and perspectives.
Becquemont L. Becquemont L. Pharmacogenomics. 2009 Jun;10(6):961-9. doi: 10.2217/pgs.09.37. Pharmacogenomics. 2009. PMID: 19530963 Review.

See all similar articles

Cited by

Genetics of immune-mediated adverse drug reactions: a comprehensive and clinical review.
Yip VL, Alfirevic A, Pirmohamed M. Yip VL, et al. Clin Rev Allergy Immunol. 2015 Jun;48(2-3):165-75. doi: 10.1007/s12016-014-8418-y. Clin Rev Allergy Immunol. 2015. PMID: 24777842 Review.
Genetic HLA Study of Kurds in Iraq, Iran and Tbilisi (Caucasus, Georgia): Relatedness and Medical Implications.
Arnaiz-Villena A, Palacio-Grüber J, Muñiz E, Campos C, Alonso-Rubio J, Gomez-Casado E, Salih SF, Martin-Villa M, Al-Qadi R. Arnaiz-Villena A, et al. PLoS One. 2017 Jan 23;12(1):e0169929. doi: 10.1371/journal.pone.0169929. eCollection 2017. PLoS One. 2017. PMID: 28114347 Free PMC article.
Clustering and alignment of polymorphic sequences for HLA-DRB1 genotyping.
Ringquist S, Bellone G, Lu Y, Roeder K, Trucco M. Ringquist S, et al. PLoS One. 2013;8(3):e59835. doi: 10.1371/journal.pone.0059835. Epub 2013 Mar 28. PLoS One. 2013. PMID: 23555798 Free PMC article.
Impact of New Genomic Technologies on Understanding Adverse Drug Reactions.
Maggo SD, Savage RL, Kennedy MA. Maggo SD, et al. Clin Pharmacokinet. 2016 Apr;55(4):419-36. doi: 10.1007/s40262-015-0324-9. Clin Pharmacokinet. 2016. PMID: 26369774 Free PMC article. Review.
HLA genetic profile of Mapuche (Araucanian) Amerindians from Chile.
Rey D, Parga-Lozano C, Moscoso J, Areces C, Enriquez-de-Salamanca M, Fernández-Honrado M, Abd-El-Fatah-Khalil S, Alonso-Rubio J, Arnaiz-Villena A. Rey D, et al. Mol Biol Rep. 2013 Jul;40(7):4257-67. doi: 10.1007/s11033-013-2509-3. Epub 2013 May 11. Mol Biol Rep. 2013. PMID: 23666052

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information
Research Materials
- NCI CPTC Antibody Characterization Program